Browse by People

Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 14.


Aslam, AA, Higgins, C, Sinha, IP and Southern, KW ORCID: 0000-0001-6516-9083 (2017) Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis. The Cochrane database of systematic reviews, 1 (1). pp. 1-20.


Neill, DR ORCID: 0000-0002-7911-8153, Saint, GL ORCID: 0000-0003-4031-4939, Bricio-Moreno, L, Fothergill, J ORCID: 0000-0002-7012-1508, Southern, KW ORCID: 0000-0001-6516-9083, Winstanley, C ORCID: 0000-0002-2662-8053, Christmas, SE, Slupsky, JR ORCID: 0000-0002-7410-9004, McNamara, PS ORCID: 0000-0002-7055-6034, Kadioglu, A ORCID: 0000-0003-1137-6321 et al (show 1 more authors) (2014) THE B LYMPHOCYTE DIFFERENTIATION FACTOR (BAFF) IS EXPRESSED IN THE AIRWAYS OF CHILDREN WITH CF AND IN LUNGS OF MICE INFECTED WITH PSEUDOMONAS AERUGINOSA. PLoS One, 9 (5). e95892-.


Munck, A, Mayell, SJ, Winters, V, Shawcross, A, Derichs, N, Parad, R, Barben, J and Southern, KW ORCID: 0000-0001-6516-9083 (2015) Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening. Journal of Cystic Fibrosis, 14 (6). pp. 706-713.


Southern, KW ORCID: 0000-0001-6516-9083, Barben, J, Gartner, S, Munck, A, Castellani, C, Mayell, SJ, Davies, JC, Winters, V, Murphy, J, Salinas, D et al (show 3 more authors) (2019) Inconclusive diagnosis after a positive newborn bloodspot screening result for cystic fibrosis; clarification of the harmonised international definition. JOURNAL OF CYSTIC FIBROSIS, 18 (6). pp. 778-780.


Chudleigh, J, Ren, CL, Barben, J and Southern, KW ORCID: 0000-0001-6516-9083 (2019) International approaches for delivery of positive newborn bloodspot screening results for CF. JOURNAL OF CYSTIC FIBROSIS, 18 (5). pp. 614-621.


Castellani, C, Massie, J, Sontag, M and Southern, KW ORCID: 0000-0001-6516-9083 (2016) Newborn screening for cystic fibrosis. The Lancet Respiratory Medicine, 4 (8). pp. 653-661.


Cirilli, N, Southern, KW ORCID: 0000-0001-6516-9083, Buzzetti, R, Barben, J, Nahrlich, L, Munck, A, Wilschanski, M, De Boeck, K, Derichs, N and Working, ECFS Diagnostic Network (2018) Real life practice of sweat testing in Europe. JOURNAL OF CYSTIC FIBROSIS, 17 (3). pp. 325-332.


Pybus, S (2016) Skin microbiome of children with cystic fibrosis. Master of Philosophy thesis, University of Liverpool.


Cirilli, N, Southern, KW ORCID: 0000-0001-6516-9083, Barben, J, Vermeulen, F, Munck, A, Wilschanski, M, Nguyen-Khoa, Thao, Aralica, M, Simmonds, NJ and De Wachter, E (2022) Standards of care guidance for sweat testing; phase two of the ECFS quality improvement programme. Journal of Cystic Fibrosis, 21 (1). pp. 434-441.


Perry, LA, Penny-Dimri, JC, Aslam, AA, Lee, TW and Southern, KW ORCID: 0000-0001-6516-9083 (2017) Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease. PAEDIATRIC RESPIRATORY REVIEWS, 22. pp. 47-49.


Perry, LA, Penny-Dimri, JC, Aslam, AA, Lee, TW and Southern, KW ORCID: 0000-0001-6516-9083 (2017) Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease. Paediatric respiratory reviews, 22. pp. 47-49.


Barben, J, Winters, V, Castellani, C, Dankert-Roelse, J, Gartner, S, Kashirskaya, N, Linnane, B, Munck, A, Sands, D, Sommerburg, O et al (show 1 more authors) (2016) UPDATED SURVEY OF NEWBORN SCREENING FOR CYSTIC FIBROSIS IN EUROPE. .


Schlüter, DK, Dryden, C, Southern, KW, Diggle, PJ and Taylor-Robinson, D (2018) WS05.1 Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: a UK Registry-based study. .


McCormack, P, Burnham, P and Southern, KW ORCID: 0000-0001-6516-9083 (2019) A systematic Cochrane Review of autogenic drainage (AD) for airway clearance in cystic fibrosis. , England.

This list was generated on Fri Sep 29 00:35:02 2023 BST.